Hey Kelpie, I am not sure if you are being sarcastic or not if...

Hey Kelpie, I am not sure if you are being sarcastic or not if you are it’s not really necessary. There is no negative component to this story. The UK market is huge and the variety of products involved in this process was also huge. To have three quarters of them fail to meet criteria is a huge boon to the Satipharm product, a product that has been well reviewed and has increasing interest within the UK. As the announcement states there are additional stocking opportunities already in place pending this announcement.

Now don’t get me wrong Satipharm did all the leg work on this up to now not CANN, all CANN did was buy the company at the right time. However from the research I have done it seems to be a great purchase that is helping to feed CANNs goal to be known as a safe and reputable supplier.